Send mail to Author

Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______     ___     ______     _____                ___    
 /_   _//   / _ \\  |      \\  |  ___||   ____      / _ \\  
   | ||    | / \ || |  --  //  | ||__    |    \\   | / \ || 
  _| ||    | \_/ || |  --  \\  | ||__    | [] ||   | \_/ || 
 /__//      \___//  |______//  |_____||  |  __//    \___//  
 `--`       `---`   `------`   `-----`   |_|`-`     `---`   
                                         `-`                
 


Back to frontdoor view